| Typicality: | 0.273 |
| Saliency: | 0.258 |
| for the closure group | 7 | transitive-object |
| clinically | 3 | manner |
| on analysis | 2 | other |
| trial → show → significant benefit | 11 |
| trial → demonstrate → significant benefit | 4 |
| negative | neutral | positive |
| 0.104 | 0.232 | 0.665 |
| Raw frequency | 15 |
| Normalized frequency | 0.258 |
| Modifier score | 0.500 |
| Perplexity | 112.024 |